Tag: Nitrosamines

If you don’t find what you are looking for, try using a different term or contact us.

FDA Releases Updated Guidance on Controlling Nitrosamine Impurities in Human Drugs

FDA Releases Updated Guidance on Controlling Nitrosamine Impurities in Human Drugs

FDA's 2024 guidance on nitrosamine impurities introduces new limits, testing methods, and timelines, focusing on NDSRIs to enhance drug safety...

BECOME A GMP INSIDER

Stay in touch and be the first to get the latest GMP News!